Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
105,670,220
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
25,799,127
-
Shares change
-
-1,125,752
-
Total reported value, excl. options
-
$322,227,437
-
Value change
-
-$12,715,178
-
Number of buys
-
29
-
Number of sells
-
-25
-
Price
-
$12.49
Significant Holders of Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) as of Q1 2019
74 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q1 2019.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,799,127 shares
of 105,670,220 outstanding shares and own 24% of the company stock.
Largest 10 shareholders include Alphabet Inc. (5,049,786 shares), WELLINGTON MANAGEMENT GROUP LLP (4,257,706 shares), Svennilson Peter (3,540,850 shares), BVF INC/IL (2,810,223 shares), BlackRock Inc. (1,831,701 shares), Foresite Capital Management III, LLC (1,366,973 shares), VANGUARD GROUP INC (1,161,946 shares), EcoR1 Capital, LLC (990,146 shares), STATE STREET CORP (541,375 shares), and JANUS HENDERSON GROUP PLC (506,848 shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.